Year Established :
2016
Total Number of Staff :
50-100
Main Competitive Advantages :
International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Small Orders Accepted
Business Type :
Manufacturer
R&D Capacity :
Own Brand
Main Sales Markets :
North America,Western Europe,Eastern Europe,Asia
Product Range :
Bemotrizinol（TS）/(S)-3-Aminobutanenitrile hydrochloride/Methyl 2-(acetoxymethyl)acrylate/Methyl 2-(hydroxymethyl)acrylate/Methyl 2-(chloromethyl)acrylate/Methyl 2-(bromomethyl)acrylate/3-Nitro-2-Methyl benzoic acid/2-Methyl-6-nitrobenzoic acid/3-Bromopyridine/2-Methyl-3-nitroanisole/2-Methyl-3-nitrophenol/2-Methyl-3-nitroaniline/(1S,2S,3R,5S)-(+)-2,3-Pinanediol/(1R,2R,3S,5R)-(-)-Pinanediol/2,5-Dimethoxybenzaldehyde/1-Isopropylpiperazine/tert-Butyl N-hydroxycarbamate/7-Methoxy-1-tetralone/3-Oxetanone/3-iodooxetane/3,5-Dimethyl-4-nitrophenol/2-Bromoethyl benzoate/3-Bromo-2-cyanopyridine/Bemotrizinol/2,2'-DIPICOLYLAMINE/2,4-dichloro-6-(4-methoxyphenyl)-1,3,5-triazine/xanthane hydride/4-Cyclopropyl-1,2,5-oxadiazole-3-carboxylic acid/Triethyl 2-phosphonobutyrate/Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate/3-Pyrrolidinepropanamide, α-amino-2-oxo-, hydrochloride/2-chlorophenylhydrazine hydrochloride/Cyclosporin A/L-tert-Leucine methyl ester hydrochloride
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
